• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Teva to Buy Leading Mexican Pharma Firm

Article

October 02, 2015.

Teva (Petah Tikva, Israel) has entered into an agreement to acquire Mexican pharma company Representaciones e Investigaciones Médicas (Rimsa) for $2.3 billion, according to Streetinsider.com.

Rimsa, which had a 2014 revenue of $227 million, has a portfolio of specialty products, including fixed-dose combination products. The company has a 45-year history as one of Mexico's companies; Mexico is the second largest healthcare market in Latin America.

Teva expects to close the transactions by Q1 2016. 

Related Videos